Japan, Jan. 27 -- BOEHRINGER INGELHEIM INTERNATL GMBH has got intellectual property rights for 'MULTI-SPECIFIC BINDING PROTEINS FOR CANCER TREATMENT.' Other related details are as follows:

Application Number: JP,2023-194494

Category (FI): A61P35/04,A61P43/00,121,A61K45/00,A61P37/04,A61P43/00,107,A61K47/68,A61K39/395@C,A61K39/395@L,A61K39/395@U,A61K39/395@G,A61K39/395@E,A61K39/395@T,A61K38/22,A61K9/08,A61K47/22,A61K47/26,A61P35/00,C12P21/08,C12N5/10,C12N1/21,C12N1/19,C12N1/15,C12N15/63@Z,C12N15/62@Z,C07K16/28,C07K16/46,C12N15/13

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Nov. 15, 2023

Publication Date: Feb. 14, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Dis...